Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis.
ALDH4A1 gene
Epilepsy
Hyperprolinemia type II
Proline
Vitamin B6 metabolism
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
29 Dec 2019
29 Dec 2019
Historique:
received:
11
09
2019
accepted:
19
12
2019
entrez:
31
12
2019
pubmed:
31
12
2019
medline:
4
3
2020
Statut:
epublish
Résumé
Hyperprolinemia type 2 (HPII) is a rare autosomal recessive disorder of the proline metabolism, that affects the ALDH4A1 gene. So far only four different pathogenic mutations are known. The manifestation is mostly in neonatal age, in early infancy or early childhood. The 64-years female patient had a long history of abdominal pain, and episode of an acute neuritis. Ten years later she was admitted into the neurological intensive-care-unit with acute abdominal pain, multiple generalized epileptic seizures, a vertical gaze palsy accompanied by extensive lactic acidosis in serum 26.0 mmol/l (reference: 0.55-2.2 mmol/l) and CSF 12.01 mmol/l (reference: 1.12-2.47 mmol/l). Due to repeated epileptic seizures and secondary complications a long-term sedation with a ventilation therapy over 20 days was administered. A diagnostic work-up revealed up to 400-times increased prolin-level in urine CSF and blood. Furthermore, a low vitamin-B We describe two novel ALDH4A1-variants in an adult patient with hyperprolinemia type II causing secondary pyridoxine deficiency and seizures. Severe and potentially life-threatening course of this treatable disease emphasizes the importance of diagnostic vigilance and thorough laboratory work-up including gene analysis even in cases with atypical late manifestation.
Sections du résumé
BACKGROUND
BACKGROUND
Hyperprolinemia type 2 (HPII) is a rare autosomal recessive disorder of the proline metabolism, that affects the ALDH4A1 gene. So far only four different pathogenic mutations are known. The manifestation is mostly in neonatal age, in early infancy or early childhood.
CASE PRESENTATION
METHODS
The 64-years female patient had a long history of abdominal pain, and episode of an acute neuritis. Ten years later she was admitted into the neurological intensive-care-unit with acute abdominal pain, multiple generalized epileptic seizures, a vertical gaze palsy accompanied by extensive lactic acidosis in serum 26.0 mmol/l (reference: 0.55-2.2 mmol/l) and CSF 12.01 mmol/l (reference: 1.12-2.47 mmol/l). Due to repeated epileptic seizures and secondary complications a long-term sedation with a ventilation therapy over 20 days was administered. A diagnostic work-up revealed up to 400-times increased prolin-level in urine CSF and blood. Furthermore, a low vitamin-B
CONCLUSION
CONCLUSIONS
We describe two novel ALDH4A1-variants in an adult patient with hyperprolinemia type II causing secondary pyridoxine deficiency and seizures. Severe and potentially life-threatening course of this treatable disease emphasizes the importance of diagnostic vigilance and thorough laboratory work-up including gene analysis even in cases with atypical late manifestation.
Identifiants
pubmed: 31884946
doi: 10.1186/s12883-019-1583-0
pii: 10.1186/s12883-019-1583-0
pmc: PMC6935479
doi:
Substances chimiques
1-Pyrroline-5-Carboxylate Dehydrogenase
EC 1.2.1.88
ALDH4A1 protein, human
EC 1.2.1.88
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
345Références
Pediatr Int. 2014 Aug;56(4):492-6
pubmed: 24931297
J Biol Chem. 2001 May 4;276(18):15107-16
pubmed: 11134058
Metab Brain Dis. 2011 Sep;26(3):159-72
pubmed: 21643764
J Inherit Metab Dis. 2014 May;37(3):383-90
pubmed: 24173411
Arch Dis Child. 1989 Dec;64(12):1699-707
pubmed: 2624476
Neurochem Res. 2012 Jan;37(1):205-13
pubmed: 21935728
Handb Clin Neurol. 2013;113:1811-7
pubmed: 23622403
Hum Mol Genet. 1998 Sep;7(9):1411-5
pubmed: 9700195